Fulton F Velez (Fulton Velez)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 12

Top Topics

Photodynamic Therapy

Top Venues

Expert review of pharmacoeconomics & outcomes research

Hospital practice (1995)

ClinicoEconomics and outcomes research : CEOR

Current medical research and opinion

This page only lists publications with an associated author ORCID identifier.

Publications

Felicia Forma, Tyler G Knight, Frances P Thorndike, Xiaorui R Xiong, Rebecca Baik, Fulton F Velez, Yuri A Maricich, Daniel C Malone
Real-World Evaluation of Clinical Response and Long-Term Healthcare Resource Utilization Patterns Following Treatment with a Digital Therapeutic for Chronic Insomnia. ClinicoEconomics and outcomes research : CEOR 14 (2022)
Fulton F Velez, Danmeng Huang, Lorie Mody, Daniel C Malone
Five-year budget impact of a prescription digital therapeutic for patients with opioid use disorder. Expert review of pharmacoeconomics & outcomes research 22 (4) (2022)
Felicia Forma, Ramya Pratiwadi, Fadoua El-Moustaid, Nathaniel Smith, Frances Thorndike, Fulton F Velez
Network meta-analysis comparing the effectiveness of a prescription digital therapeutic for chronic insomnia to medications and face-to-face cognitive behavioral therapy in adults. Current medical research and opinion 38 (10) (2022)
Fulton F Velez, Hilary F Luderer, Robert Gerwien, Benjamin Parcher, Dylan Mezzio, Daniel C Malone
Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder. Postgraduate medicine 133 (4) (2021)
Fulton F Velez, Charles Ruetsch, Yuri Maricich
Evidence of long-term real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic. Expert review of pharmacoeconomics & outcomes research 21 (4) (2021)
Yuri A Maricich, Robert Gerwien, Alice Kuo, Daniel C Malone, Fulton F Velez
Real-world use and clinical outcomes after 24 weeks of treatment with a prescription digital therapeutic for opioid use disorder. Hospital practice (1995) (2021)
Fulton F Velez, Sam Colman, Laura Kauffman, Charles Ruetsch, Kathryn P Anastassopoulos, Yuri A Maricich
Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder. ClinicoEconomics and outcomes research : CEOR 13 (2021)
Fulton F Velez, Sam Colman, Laura Kauffman, Kathryn Anastassopoulos, Sean Murphy, Yuri Maricich
Real-world changes in US health system hospital-based services following treatment with a prescription digital therapeutic for opioid use disorder. Hospital practice (1995) (2021)
Fulton F Velez, Daniel C Malone
Cost-Effectiveness Analysis of a Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder. Journal of market access & health policy 9 (1) (2021)
Zachary M Soler, Sam Colman, Fulton F Velez, Rodney J Schlosser
Exhalation delivery system with fluticasone improves quality of life and health status: pooled analysis of phase 3 trials NAVIGATE I and II. International forum of allergy & rhinology 10 (7) (2020)
Fulton F Velez, Sam Colman, Laura Kauffman, Charles Ruetsch, Kathryn Anastassopoulos
Real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic. Expert review of pharmacoeconomics & outcomes research 21 (1) (2020)
Yuri A Maricich, Xiaorui Xiong, Robert Gerwien, Alice Kuo, Fulton F Velez, Bruce Imbert, Keely Boyer, Hilary F Luderer, Stephen Braun, Karren Williams
Real-world evidence for a prescription digital therapeutic to treat opioid use disorder. Current medical research and opinion 37 (2) (2020)